CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
1.775
-0.085 (-4.57%)
At close: Aug 13, 2025, 4:00 PM
1.830
+0.055 (3.10%)
Pre-market: Aug 14, 2025, 9:07 AM EDT

CytomX Therapeutics Statistics

Total Valuation

CTMX has a market cap or net worth of $292.72 million. The enterprise value is $141.52 million.

Market Cap 292.72M
Enterprise Value 141.52M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

CTMX has 164.91 million shares outstanding. The number of shares has increased by 17.52% in one year.

Current Share Class 164.91M
Shares Outstanding 164.91M
Shares Change (YoY) +17.52%
Shares Change (QoQ) +48.11%
Owned by Insiders (%) 0.60%
Owned by Institutions (%) 35.22%
Float 126.30M

Valuation Ratios

The trailing PE ratio is 3.63.

PE Ratio 3.63
Forward PE n/a
PS Ratio 1.22
Forward PS n/a
PB Ratio 2.44
P/TBV Ratio 2.47
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 2.95
EV / Sales 1.00
EV / EBITDA 3.17
EV / EBIT 3.28
EV / FCF n/a

Financial Position

The company has a current ratio of 4.20, with a Debt / Equity ratio of 0.06.

Current Ratio 4.20
Quick Ratio 4.08
Debt / Equity 0.06
Debt / EBITDA 0.14
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 108.21% and return on invested capital (ROIC) is 50.23%.

Return on Equity (ROE) 108.21%
Return on Assets (ROA) 16.13%
Return on Invested Capital (ROIC) 50.23%
Return on Capital Employed (ROCE) 31.75%
Revenue Per Employee $1.17M
Profits Per Employee $396,554
Employee Count 121
Asset Turnover 0.84
Inventory Turnover n/a

Taxes

In the past 12 months, CTMX has paid $249,000 in taxes.

Income Tax 249,000
Effective Tax Rate 0.52%

Stock Price Statistics

The stock price has increased by +49.16% in the last 52 weeks. The beta is 2.13, so CTMX's price volatility has been higher than the market average.

Beta (5Y) 2.13
52-Week Price Change +49.16%
50-Day Moving Average 2.38
200-Day Moving Average 1.34
Relative Strength Index (RSI) 33.51
Average Volume (20 Days) 2,399,605

Short Selling Information

The latest short interest is 23.96 million, so 14.53% of the outstanding shares have been sold short.

Short Interest 23.96M
Short Previous Month 23.87M
Short % of Shares Out 14.53%
Short % of Float 18.97%
Short Ratio (days to cover) 15.97

Income Statement

In the last 12 months, CTMX had revenue of $141.10 million and earned $47.98 million in profits. Earnings per share was $0.49.

Revenue 141.10M
Gross Profit 141.10M
Operating Income 43.13M
Pretax Income 15.08M
Net Income 47.98M
EBITDA 44.70M
EBIT 43.13M
Earnings Per Share (EPS) $0.49
Full Income Statement

Balance Sheet

The company has $158.09 million in cash and $6.89 million in debt, giving a net cash position of $151.20 million or $0.92 per share.

Cash & Cash Equivalents 158.09M
Total Debt 6.89M
Net Cash 151.20M
Net Cash Per Share $0.92
Equity (Book Value) 119.91M
Book Value Per Share 0.73
Working Capital 125.40M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$77.43 million and capital expenditures -$245,000, giving a free cash flow of -$77.68 million.

Operating Cash Flow -77.43M
Capital Expenditures -245,000
Free Cash Flow -77.68M
FCF Per Share -$0.47
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 30.56% and 34.01%.

Gross Margin 100.00%
Operating Margin 30.56%
Pretax Margin 34.18%
Profit Margin 34.01%
EBITDA Margin 31.68%
EBIT Margin 30.56%
FCF Margin n/a

Dividends & Yields

CTMX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -17.52%
Shareholder Yield -17.52%
Earnings Yield 16.39%
FCF Yield -26.54%

Analyst Forecast

The average price target for CTMX is $5.67, which is 219.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.67
Price Target Difference 219.44%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 4.50%
EPS Growth Forecast (5Y) -35.91%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CTMX has an Altman Z-Score of -1.58 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -1.58
Piotroski F-Score 4